Search

Your search keyword '"Rieprecht, Susanne"' showing total 3 results
Start Over Author "Rieprecht, Susanne"
3 results on '"Rieprecht, Susanne"'

1. Steady‐state versus chemotherapy‐based hematopoietic cell mobilization after anti‐CD38‐based induction therapy in newly diagnosed multiple myeloma

Author

Teipel, Raphael, primary, Rieprecht, Susanne, additional, Trautmann‐Grill, Karolin, additional, Röllig, Christoph, additional, Klötzer, Christina, additional, Zimmer, Kristin, additional, Rathaj, Grit, additional, Bach, Enrica, additional, Brückner, Mandy, additional, Heyn, Simone, additional, Wang, Song‐Yau, additional, Jentzsch, Madlen, additional, Schwind, Sebastian, additional, Kretschmann, Theresa, additional, Egger‐Heidrich, Katharina, additional, Remane, Yvonne, additional, Franke, Georg‐Nikolaus, additional, von Bonin, Malte, additional, Bornhäuser, Martin, additional, Platzbecker, Uwe, additional, Hölig, Kristina, additional, Merz, Maximilian, additional, and Vučinić, Vladan, additional

Published
2023
Full Text
View/download PDF

2. Analysis of stem cell collections in adult patients with Ewing sarcoma

Author

Franke, Georg‐Nikolaus, primary, Pfannes, Roald, additional, Heyn, Simone, additional, Brückner, Mandy, additional, Rieprecht, Susanne, additional, Bach, Enrica, additional, Remane, Yvonne, additional, Leiblein, Sabine, additional, Pönisch, Wolfram, additional, Niederwieser, Dietger, additional, Schwind, Sebastian, additional, Platzbecker, Uwe, additional, Jentzsch, Madlen, additional, and Vucinic, Vladan, additional

Published
2022
Full Text
View/download PDF

3. Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible

Author

Vucinic, Vladan, Jentzsch, Madlen, Schwind, Sebastian, Bach, Enrica, Leiblein, Sabine, Remane, Yvonne, Rieprecht, Susanne, Otto, Sandra, Kubasch, Anne-Sophie, Behre, Gerhard, Cross, Michael, Platzbecker, Uwe, and Franke, Georg-Nikolaus

Subjects
CPX-351, induction therapy, Case Report, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, therapy-related acute myeloid leukemia, surgical procedures, operative, Oncology, hematopoeietic stem cell transplantation, hemic and lymphatic diseases, AML-MRC, ddc:610, CPX-351, AML-MRC, therapy-related acute myeloid leukemia, induction therapy, hematopoeietic stem cell transplantation, prognosis, prognosis
Abstract

Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) and treatment-related acute myeloid leukemia (tAML) after chemotherapy or radiation therapy for other neoplasms are associated with poor outcomes. CPX-351, a dual-drug liposomal encapsulation of daunorubicin and cytarabine, has been shown to improve outcomes in AML-MRC and tAML compared with standard 7+3 regimens. Here we report the cases of four consecutive patients with AML-MRC or tAML who received CPX-351 as outpatient induction therapy immediately followed by allogeneic hematopoietic stem cell transplantation (allo-HSCT). Two patients received allo-HSCT in remission (one in complete remission and one in partial remission) and two patients received allo-HSCT in aplasia (one at 11 days and one at 52 days after the start of induction therapy with CPX-351). With a median follow-up of 188 days after allo-HSCT, all but one patient are alive and two are in remission. Further studies will help define and expand the role of CPX-351 in the treatment of AML-MRC and tAML, especially in patients expected to undergo allo-HSCT.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results